Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Emergent Biosolutions Inc (EBS)

186 + Investors. Track Smart Money conviction in EBS. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +7
Streak
3Q ▲
Buyers last Q
56%

Smart Money Signals — EBS

Based on 188 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds added EBS than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
188 hedge funds hold EBS right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +16% more funds vs a year ago

fund count last 6Q
+26 new funds entered over the past year (+16% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 56% buying

105 buying81 selling
Last quarter: 105 funds bought or added vs 81 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-6 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 41 → 38 → 40 → 34. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

59% of holders stayed for 2+ years

■ 59% conviction (2yr+) ■ 17% medium ■ 24% new
111 out of 188 hedge funds have held EBS for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares -2%, value -37%

Value
-37%
Shares
-1%
Last quarter: funds added -2% more shares while total portfolio value only changed -37%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
➡️

Steady discovery — ~34 new funds/quarter

35 → 41 → 38 → 40 → 34 new funds/Q
New funds entering each quarter: 41 → 38 → 40 → 34. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Deep conviction — 66% of holders stayed 2+ years

■ 66% veterans ■ 8% 1-2yr ■ 25% new
Of 193 current holders: 128 (66%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
🏆

Elite ownership — 45% AUM from top-100 funds

45% from top-100 AUM funds
40 of 188 holders are among the 100 largest funds by AUM, controlling 45% of total institutional value in EBS. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.8
out of 10
Low Exit Risk
Exit risk score 3.8/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — EBS

In 2026 Q1, 105 hedge funds were net buyers of EBS (34 opened a new position, 71 added to an existing one), while 81 reduced or exited (54 trimmed, 27 sold completely) — a 56% buyer ratio, indicating a slight buying edge. This marks 3 consecutive quarters of net institutional buying — a persistent conviction signal. 45% of total institutional value in EBS is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +7 funds (more new holders than closures). Total institutional holders: 188.

Hedge Fund Ownership: EBS

How many hedge funds hold EBS — quarterly history vs. share price
Quarterly hedge fund ownership of EBS vs. share price

Market Analysis: EBS

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: EBS

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Emergent Biosolutions Inc (EBS) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much EBS has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 79d ago
EBS
-1.9%
XLV
+2.8%

EBS outperformed XLV by -4.7% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 34d ago
EBS
+2.5%
XLV
+3.9%

Since the filing became public, EBS outperformed XLV by -1.4% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

15 top-rated funds 0 high-conviction
Consensus
5.2
/ 10
breadth
×
Elite
0.4
/ 10
conviction
Hedge Fund Positioning: EBS
186 + Investors

Track Smart Money conviction in EBS. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 186 181 2.76%
13F Shares 43M 44M -1.75%
Total Value $340M $544M -37.5%
New Positions 34 40 -6
Increased Positions 68 60 +8
Closed Positions 29 29 -
Reduced Positions 53 51 +2
Total Calls 4 5 -20.0%
Total Puts 3 4 -25.0%
PUT/CALL Ratio 0.75 0.8 Neutral

Statistics: EBS

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

186 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in EBS. Verified SEC 13F-HR filings.

QUARTER:
Top 25 EBS holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Values First Advisors, Inc. 1.33% 307,880 $2.6M
2 Oak Hill Advisors LP 1.05% 1,113,338 $9.2M
3 Prosight Management, LP 0.87% 639,118 $5.3M
4 Prescott Group Capital Management, L.L.C. 0.64% 772,771 $6.4M
5 Morse Asset Management, Inc 0.38% 221,799 $1.8M
6 Palisade Capital Management, LP 0.33% 1,201,323 $10.0M
7 Globeflex Capital L P 0.30% 241,298 $2.0M
8 Oxford Asset Management LLP 0.21% 57,638 $478K
9 Palumbo Wealth Management LLC 0.16% 80,264 $666K
10 Stirlingshire Investments, Inc. 0.14% 19,285 $160K
11 Virtus Advisers, LLC 0.08% 19,500 $162K
12 Ancora Advisors LLC 0.07% 409,267 $3.4M
13 Silver Oak Securities, Incorporated 0.06% 106,700 $886K
14 James Investment Research, INC. 0.06% 61,963 $514K
15 Baron Wealth Management LLC 0.04% 15,120 $125K
16 EntryPoint Capital, LLC 0.04% 14,577 $121K
17 Trexquant Investment LP 0.03% 524,233 $4.4M
18 Evolve Private Wealth, LLC 0.03% 65,754 $546K
19 Aster Capital Management (DIFC) Ltd 0.02% 15,337 $75K
20 L2 Asset Management, LLC 0.02% 25,782 $214K
21 State of Wyoming 0.02% 20,011 $166K
22 Susquehanna Portfolio Strategies, LLC 0.02% 156,443 $1.3M
23 Herold Advisors, Inc. 0.02% 10,000 $83K
24 Axq Capital, LP 0.02% 17,004 $141K
25 Abel Hall, LLC 0.02% 10,106 $84K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Emergent Biosolutions Inc (EBS)

What does the Smart Money Trend signal show for EBS?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added EBS than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for EBS?

Slight buying edge — 56% buying: Last quarter: 105 funds bought or added vs 81 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for EBS holders?

Elite ownership — 45% AUM from top-100 funds: 40 of 188 holders are among the 100 largest funds by AUM, controlling 45% of total institutional value in EBS. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held EBS?

59% of holders stayed for 2+ years: 111 out of 188 hedge funds have held EBS for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Emergent Biosolutions Inc (EBS) following the 2026 Q1 hedge fund 13F filings?

As of today, EBS has moved +2.5% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.9% for the XLV sector ETF — an outperformance of -1.4%. Since the quarter end (March 31, 2026), EBS has gained -1.9% vs +2.8% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →